PDI, a global leader in infection prevention products and solutions, launched its Sani-Cloth Bleach Clinical Size Wipe, a 6 by 5 inch disinfecting wipe ideal for smaller medical equipment, thereby helping to reduce unnecessary waste. The Clinical Size Wipe uses PDI’s proven Sani-ClothBleach formulation, which deactivates 50 different microorganisms including SARS-CoV-2, the virus that causes COVID-19.
 

PDI has initially prioritized the new product for COVID-19 testing sites. The smaller wipe size and compatibility profile offered by the Sani-Cloth Bleach formulation makes the clinical size wipe an ideal option for disinfecting the devices used for testing.
 

“The increased demand driven by COVID-19 has resulted in PDI taking a critical look at optimizing all variables of the supply chain while continuing to meet the needs of our customers” says Sean Gallimore, senior vice president and general manager, PDI Healthcare. “The new Sani-Cloth Bleach Clinical Size Wipe provides our powerful bleach formulation in the ideal size for disinfecting smaller medical equipment. By offering a smaller wipe size, we can provide more than double the disinfection applications per canister.”
 

As the company ramps up production, the Sani-Cloth Bleach Clinical Size Wipe will be available more broadly to healthcare facilities with the full line of Sani-Cloth products, including large and extra-large sizes.
 

The expansion of the Sani-Cloth Bleach Wipes product family is part of PDI’s ongoing commitment to offering customers a layered approach for effective infection prevention that features proven products, technologies, and education.